Global CAR T-Cell Therapy Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Corrosion Under Insulation (CUI) Monitoring market size is predicted to grow from US$ 214 million in 2025 to US$ 260 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.
Corrosion under insulation (CUI) poses a significant operational loss, safety hazard and economic cost. Corrosion under insulation (CUI) is invisible to the surface of the insulation. Because of this, it is very difficult for conventional techniques to detect and monitor corrosion under insulation. The presence of moisture in and under insulation is the root cause of corrosion under insulation (CUI). Corrosion under insulation is a severe form of localized external corrosion that occurs in carbon and low alloy steel equipment that has been insulated. This form of corrosion occurs when water is absorbed by or collected in the insulation. As a result he equipment begins to corrode as it is exposed to water and oxygen. Depending on the structure and the location of the insulation, CUI can attack the jacketing, insulation hardware or underlying piping equipment. Additionally, when insulation becomes wet or absorbs moisture, its thermal insulating properties are drastically reduced. Because water conducts heat more efficiently than air, an aggressive corrosion cell is created where the trapped heat accelerates the rate of corrosion.
Global key players of Corrosion Under Insulation (CUI) Monitoring include Mistras, QSA Global, Inc. , Previan (Eddyfi), Kaefer Group, Alabama Specialty Products (Metal Samples) and Applied Technical Services, LLC, etc. The top six manufacturers hold a share over 65%.
LPI (LP Information)' newest research report, the “Corrosion Under Insulation (CUI) Monitoring Industry Forecast” looks at past sales and reviews total world Corrosion Under Insulation (CUI) Monitoring sales in 2024, providing a comprehensive analysis by region and market sector of projected Corrosion Under Insulation (CUI) Monitoring sales for 2025 through 2031. With Corrosion Under Insulation (CUI) Monitoring sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Corrosion Under Insulation (CUI) Monitoring industry.
This Insight Report provides a comprehensive analysis of the global Corrosion Under Insulation (CUI) Monitoring landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Corrosion Under Insulation (CUI) Monitoring portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Corrosion Under Insulation (CUI) Monitoring market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Corrosion Under Insulation (CUI) Monitoring and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Corrosion Under Insulation (CUI) Monitoring.
This report presents a comprehensive overview, market shares, and growth opportunities of Corrosion Under Insulation (CUI) Monitoring market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Corrosion Under Insulation (CUI) Monitoring market size is predicted to grow from US$ 214 million in 2025 to US$ 260 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.
Corrosion under insulation (CUI) poses a significant operational loss, safety hazard and economic cost. Corrosion under insulation (CUI) is invisible to the surface of the insulation. Because of this, it is very difficult for conventional techniques to detect and monitor corrosion under insulation. The presence of moisture in and under insulation is the root cause of corrosion under insulation (CUI). Corrosion under insulation is a severe form of localized external corrosion that occurs in carbon and low alloy steel equipment that has been insulated. This form of corrosion occurs when water is absorbed by or collected in the insulation. As a result he equipment begins to corrode as it is exposed to water and oxygen. Depending on the structure and the location of the insulation, CUI can attack the jacketing, insulation hardware or underlying piping equipment. Additionally, when insulation becomes wet or absorbs moisture, its thermal insulating properties are drastically reduced. Because water conducts heat more efficiently than air, an aggressive corrosion cell is created where the trapped heat accelerates the rate of corrosion.
Global key players of Corrosion Under Insulation (CUI) Monitoring include Mistras, QSA Global, Inc. , Previan (Eddyfi), Kaefer Group, Alabama Specialty Products (Metal Samples) and Applied Technical Services, LLC, etc. The top six manufacturers hold a share over 65%.
LPI (LP Information)' newest research report, the “Corrosion Under Insulation (CUI) Monitoring Industry Forecast” looks at past sales and reviews total world Corrosion Under Insulation (CUI) Monitoring sales in 2024, providing a comprehensive analysis by region and market sector of projected Corrosion Under Insulation (CUI) Monitoring sales for 2025 through 2031. With Corrosion Under Insulation (CUI) Monitoring sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Corrosion Under Insulation (CUI) Monitoring industry.
This Insight Report provides a comprehensive analysis of the global Corrosion Under Insulation (CUI) Monitoring landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Corrosion Under Insulation (CUI) Monitoring portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Corrosion Under Insulation (CUI) Monitoring market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Corrosion Under Insulation (CUI) Monitoring and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Corrosion Under Insulation (CUI) Monitoring.
This report presents a comprehensive overview, market shares, and growth opportunities of Corrosion Under Insulation (CUI) Monitoring market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Hardware
- Software
- Services
- Oil & Gas
- Marine
- Chemical & Petrochemical
- Energy & Power
- Food Processing Industries
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Mistras
- QSA Global, Inc.
- Previan (Eddyfi)
- Kaefer Group
- Alabama Specialty Products (Metal Samples)
- Applied Technical Services, LLC
- Testex Inc
- Rohrback Cosasco Systems (RCS)
- 3-Sci Limited
- CorrosionRADAR
- iSensPro
- ESR Technology
- Maxwell NDT
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR T-Cell Therapy Market Size (2020-2031)
2.1.2 CAR T-Cell Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for CAR T-Cell Therapy by Country/Region (2020, 2024 & 2031)
2.2 CAR T-Cell Therapy Segment by Type
2.2.1 CD19 - Targeted
2.2.2 BCMA - Targeted
2.3 CAR T-Cell Therapy Market Size by Type
2.3.1 CAR T-Cell Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global CAR T-Cell Therapy Market Size Market Share by Type (2020-2025)
2.4 CAR T-Cell Therapy Segment by Application
2.4.1 Lymphoma
2.4.2 Multiple Myeloma
2.5 CAR T-Cell Therapy Market Size by Application
2.5.1 CAR T-Cell Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global CAR T-Cell Therapy Market Size Market Share by Application (2020-2025)
3 CAR T-CELL THERAPY MARKET SIZE BY PLAYER
3.1 CAR T-Cell Therapy Market Size Market Share by Player
3.1.1 Global CAR T-Cell Therapy Revenue by Player (2020-2025)
3.1.2 Global CAR T-Cell Therapy Revenue Market Share by Player (2020-2025)
3.2 Global CAR T-Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR T-CELL THERAPY BY REGION
4.1 CAR T-Cell Therapy Market Size by Region (2020-2025)
4.2 Global CAR T-Cell Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas CAR T-Cell Therapy Market Size Growth (2020-2025)
4.4 APAC CAR T-Cell Therapy Market Size Growth (2020-2025)
4.5 Europe CAR T-Cell Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa CAR T-Cell Therapy Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas CAR T-Cell Therapy Market Size by Country (2020-2025)
5.2 Americas CAR T-Cell Therapy Market Size by Type (2020-2025)
5.3 Americas CAR T-Cell Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR T-Cell Therapy Market Size by Region (2020-2025)
6.2 APAC CAR T-Cell Therapy Market Size by Type (2020-2025)
6.3 APAC CAR T-Cell Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CAR T-Cell Therapy Market Size by Country (2020-2025)
7.2 Europe CAR T-Cell Therapy Market Size by Type (2020-2025)
7.3 Europe CAR T-Cell Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR T-Cell Therapy by Region (2020-2025)
8.2 Middle East & Africa CAR T-Cell Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa CAR T-Cell Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CAR T-CELL THERAPY MARKET FORECAST
10.1 Global CAR T-Cell Therapy Forecast by Region (2026-2031)
10.1.1 Global CAR T-Cell Therapy Forecast by Region (2026-2031)
10.1.2 Americas CAR T-Cell Therapy Forecast
10.1.3 APAC CAR T-Cell Therapy Forecast
10.1.4 Europe CAR T-Cell Therapy Forecast
10.1.5 Middle East & Africa CAR T-Cell Therapy Forecast
10.2 Americas CAR T-Cell Therapy Forecast by Country (2026-2031)
10.2.1 United States Market CAR T-Cell Therapy Forecast
10.2.2 Canada Market CAR T-Cell Therapy Forecast
10.2.3 Mexico Market CAR T-Cell Therapy Forecast
10.2.4 Brazil Market CAR T-Cell Therapy Forecast
10.3 APAC CAR T-Cell Therapy Forecast by Region (2026-2031)
10.3.1 China CAR T-Cell Therapy Market Forecast
10.3.2 Japan Market CAR T-Cell Therapy Forecast
10.3.3 Korea Market CAR T-Cell Therapy Forecast
10.3.4 Southeast Asia Market CAR T-Cell Therapy Forecast
10.3.5 India Market CAR T-Cell Therapy Forecast
10.3.6 Australia Market CAR T-Cell Therapy Forecast
10.4 Europe CAR T-Cell Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market CAR T-Cell Therapy Forecast
10.4.2 France Market CAR T-Cell Therapy Forecast
10.4.3 UK Market CAR T-Cell Therapy Forecast
10.4.4 Italy Market CAR T-Cell Therapy Forecast
10.4.5 Russia Market CAR T-Cell Therapy Forecast
10.5 Middle East & Africa CAR T-Cell Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market CAR T-Cell Therapy Forecast
10.5.2 South Africa Market CAR T-Cell Therapy Forecast
10.5.3 Israel Market CAR T-Cell Therapy Forecast
10.5.4 Turkey Market CAR T-Cell Therapy Forecast
10.6 Global CAR T-Cell Therapy Forecast by Type (2026-2031)
10.7 Global CAR T-Cell Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market CAR T-Cell Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis CAR T-Cell Therapy Product Offered
11.1.3 Novartis CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences CAR T-Cell Therapy Product Offered
11.2.3 Gilead Sciences CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb CAR T-Cell Therapy Product Offered
11.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 J & J
11.4.1 J & J Company Information
11.4.2 J & J CAR T-Cell Therapy Product Offered
11.4.3 J & J CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 J & J Main Business Overview
11.4.5 J & J Latest Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Information
11.5.2 JW Therapeutics CAR T-Cell Therapy Product Offered
11.5.3 JW Therapeutics CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 JW Therapeutics Main Business Overview
11.5.5 JW Therapeutics Latest Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Information
11.6.2 FOSUNKite CAR T-Cell Therapy Product Offered
11.6.3 FOSUNKite CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 FOSUNKite Main Business Overview
11.6.5 FOSUNKite Latest Developments
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Information
11.7.2 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product Offered
11.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 CARsgen Therapeutics (Pipeline) Main Business Overview
11.7.5 CARsgen Therapeutics (Pipeline) Latest Developments
11.8 Autolus Therapeutics(Pipeline)
11.8.1 Autolus Therapeutics(Pipeline) Company Information
11.8.2 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product Offered
11.8.3 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Autolus Therapeutics(Pipeline) Main Business Overview
11.8.5 Autolus Therapeutics(Pipeline) Latest Developments
11.9 Sorrento Therapeutics(Pipeline)
11.9.1 Sorrento Therapeutics(Pipeline) Company Information
11.9.2 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product Offered
11.9.3 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Sorrento Therapeutics(Pipeline) Main Business Overview
11.9.5 Sorrento Therapeutics(Pipeline) Latest Developments
11.10 Mustang Bio(Pipeline)
11.10.1 Mustang Bio(Pipeline) Company Information
11.10.2 Mustang Bio(Pipeline) CAR T-Cell Therapy Product Offered
11.10.3 Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Mustang Bio(Pipeline) Main Business Overview
11.10.5 Mustang Bio(Pipeline) Latest Developments
11.11 Bluebird Bio(Pipeline)
11.11.1 Bluebird Bio(Pipeline) Company Information
11.11.2 Bluebird Bio(Pipeline) CAR T-Cell Therapy Product Offered
11.11.3 Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Bluebird Bio(Pipeline) Main Business Overview
11.11.5 Bluebird Bio(Pipeline) Latest Developments
11.12 Cellectis(Pipeline)
11.12.1 Cellectis(Pipeline) Company Information
11.12.2 Cellectis(Pipeline) CAR T-Cell Therapy Product Offered
11.12.3 Cellectis(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Cellectis(Pipeline) Main Business Overview
11.12.5 Cellectis(Pipeline) Latest Developments
11.13 Allogene Therapeutics(Pipeline)
11.13.1 Allogene Therapeutics(Pipeline) Company Information
11.13.2 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product Offered
11.13.3 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Allogene Therapeutics(Pipeline) Main Business Overview
11.13.5 Allogene Therapeutics(Pipeline) Latest Developments
11.14 Celyad(Pipeline)
11.14.1 Celyad(Pipeline) Company Information
11.14.2 Celyad(Pipeline) CAR T-Cell Therapy Product Offered
11.14.3 Celyad(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Celyad(Pipeline) Main Business Overview
11.14.5 Celyad(Pipeline) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR T-Cell Therapy Market Size (2020-2031)
2.1.2 CAR T-Cell Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for CAR T-Cell Therapy by Country/Region (2020, 2024 & 2031)
2.2 CAR T-Cell Therapy Segment by Type
2.2.1 CD19 - Targeted
2.2.2 BCMA - Targeted
2.3 CAR T-Cell Therapy Market Size by Type
2.3.1 CAR T-Cell Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global CAR T-Cell Therapy Market Size Market Share by Type (2020-2025)
2.4 CAR T-Cell Therapy Segment by Application
2.4.1 Lymphoma
2.4.2 Multiple Myeloma
2.5 CAR T-Cell Therapy Market Size by Application
2.5.1 CAR T-Cell Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global CAR T-Cell Therapy Market Size Market Share by Application (2020-2025)
3 CAR T-CELL THERAPY MARKET SIZE BY PLAYER
3.1 CAR T-Cell Therapy Market Size Market Share by Player
3.1.1 Global CAR T-Cell Therapy Revenue by Player (2020-2025)
3.1.2 Global CAR T-Cell Therapy Revenue Market Share by Player (2020-2025)
3.2 Global CAR T-Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR T-CELL THERAPY BY REGION
4.1 CAR T-Cell Therapy Market Size by Region (2020-2025)
4.2 Global CAR T-Cell Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas CAR T-Cell Therapy Market Size Growth (2020-2025)
4.4 APAC CAR T-Cell Therapy Market Size Growth (2020-2025)
4.5 Europe CAR T-Cell Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa CAR T-Cell Therapy Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas CAR T-Cell Therapy Market Size by Country (2020-2025)
5.2 Americas CAR T-Cell Therapy Market Size by Type (2020-2025)
5.3 Americas CAR T-Cell Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR T-Cell Therapy Market Size by Region (2020-2025)
6.2 APAC CAR T-Cell Therapy Market Size by Type (2020-2025)
6.3 APAC CAR T-Cell Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CAR T-Cell Therapy Market Size by Country (2020-2025)
7.2 Europe CAR T-Cell Therapy Market Size by Type (2020-2025)
7.3 Europe CAR T-Cell Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR T-Cell Therapy by Region (2020-2025)
8.2 Middle East & Africa CAR T-Cell Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa CAR T-Cell Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CAR T-CELL THERAPY MARKET FORECAST
10.1 Global CAR T-Cell Therapy Forecast by Region (2026-2031)
10.1.1 Global CAR T-Cell Therapy Forecast by Region (2026-2031)
10.1.2 Americas CAR T-Cell Therapy Forecast
10.1.3 APAC CAR T-Cell Therapy Forecast
10.1.4 Europe CAR T-Cell Therapy Forecast
10.1.5 Middle East & Africa CAR T-Cell Therapy Forecast
10.2 Americas CAR T-Cell Therapy Forecast by Country (2026-2031)
10.2.1 United States Market CAR T-Cell Therapy Forecast
10.2.2 Canada Market CAR T-Cell Therapy Forecast
10.2.3 Mexico Market CAR T-Cell Therapy Forecast
10.2.4 Brazil Market CAR T-Cell Therapy Forecast
10.3 APAC CAR T-Cell Therapy Forecast by Region (2026-2031)
10.3.1 China CAR T-Cell Therapy Market Forecast
10.3.2 Japan Market CAR T-Cell Therapy Forecast
10.3.3 Korea Market CAR T-Cell Therapy Forecast
10.3.4 Southeast Asia Market CAR T-Cell Therapy Forecast
10.3.5 India Market CAR T-Cell Therapy Forecast
10.3.6 Australia Market CAR T-Cell Therapy Forecast
10.4 Europe CAR T-Cell Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market CAR T-Cell Therapy Forecast
10.4.2 France Market CAR T-Cell Therapy Forecast
10.4.3 UK Market CAR T-Cell Therapy Forecast
10.4.4 Italy Market CAR T-Cell Therapy Forecast
10.4.5 Russia Market CAR T-Cell Therapy Forecast
10.5 Middle East & Africa CAR T-Cell Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market CAR T-Cell Therapy Forecast
10.5.2 South Africa Market CAR T-Cell Therapy Forecast
10.5.3 Israel Market CAR T-Cell Therapy Forecast
10.5.4 Turkey Market CAR T-Cell Therapy Forecast
10.6 Global CAR T-Cell Therapy Forecast by Type (2026-2031)
10.7 Global CAR T-Cell Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market CAR T-Cell Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis CAR T-Cell Therapy Product Offered
11.1.3 Novartis CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences CAR T-Cell Therapy Product Offered
11.2.3 Gilead Sciences CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb CAR T-Cell Therapy Product Offered
11.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 J & J
11.4.1 J & J Company Information
11.4.2 J & J CAR T-Cell Therapy Product Offered
11.4.3 J & J CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 J & J Main Business Overview
11.4.5 J & J Latest Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Information
11.5.2 JW Therapeutics CAR T-Cell Therapy Product Offered
11.5.3 JW Therapeutics CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 JW Therapeutics Main Business Overview
11.5.5 JW Therapeutics Latest Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Information
11.6.2 FOSUNKite CAR T-Cell Therapy Product Offered
11.6.3 FOSUNKite CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 FOSUNKite Main Business Overview
11.6.5 FOSUNKite Latest Developments
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Information
11.7.2 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product Offered
11.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 CARsgen Therapeutics (Pipeline) Main Business Overview
11.7.5 CARsgen Therapeutics (Pipeline) Latest Developments
11.8 Autolus Therapeutics(Pipeline)
11.8.1 Autolus Therapeutics(Pipeline) Company Information
11.8.2 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product Offered
11.8.3 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Autolus Therapeutics(Pipeline) Main Business Overview
11.8.5 Autolus Therapeutics(Pipeline) Latest Developments
11.9 Sorrento Therapeutics(Pipeline)
11.9.1 Sorrento Therapeutics(Pipeline) Company Information
11.9.2 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product Offered
11.9.3 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Sorrento Therapeutics(Pipeline) Main Business Overview
11.9.5 Sorrento Therapeutics(Pipeline) Latest Developments
11.10 Mustang Bio(Pipeline)
11.10.1 Mustang Bio(Pipeline) Company Information
11.10.2 Mustang Bio(Pipeline) CAR T-Cell Therapy Product Offered
11.10.3 Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Mustang Bio(Pipeline) Main Business Overview
11.10.5 Mustang Bio(Pipeline) Latest Developments
11.11 Bluebird Bio(Pipeline)
11.11.1 Bluebird Bio(Pipeline) Company Information
11.11.2 Bluebird Bio(Pipeline) CAR T-Cell Therapy Product Offered
11.11.3 Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Bluebird Bio(Pipeline) Main Business Overview
11.11.5 Bluebird Bio(Pipeline) Latest Developments
11.12 Cellectis(Pipeline)
11.12.1 Cellectis(Pipeline) Company Information
11.12.2 Cellectis(Pipeline) CAR T-Cell Therapy Product Offered
11.12.3 Cellectis(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Cellectis(Pipeline) Main Business Overview
11.12.5 Cellectis(Pipeline) Latest Developments
11.13 Allogene Therapeutics(Pipeline)
11.13.1 Allogene Therapeutics(Pipeline) Company Information
11.13.2 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product Offered
11.13.3 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Allogene Therapeutics(Pipeline) Main Business Overview
11.13.5 Allogene Therapeutics(Pipeline) Latest Developments
11.14 Celyad(Pipeline)
11.14.1 Celyad(Pipeline) Company Information
11.14.2 Celyad(Pipeline) CAR T-Cell Therapy Product Offered
11.14.3 Celyad(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Celyad(Pipeline) Main Business Overview
11.14.5 Celyad(Pipeline) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. CART-CellTherapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. CART-CellTherapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of CD19 -Targeted
Table 4. Major Players of BCMA -Targeted
Table 5. CART-CellTherapy Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global CART-CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 7. Global CART-CellTherapy Market Size Market Share byType (2020-2025)
Table 8. CART-CellTherapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global CART-CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 10. Global CART-CellTherapy Market Size Market Share by Application (2020-2025)
Table 11. Global CART-CellTherapy Revenue by Player (2020-2025) & ($ millions)
Table 12. Global CART-CellTherapy Revenue Market Share by Player (2020-2025)
Table 13. CART-CellTherapy Key Players Head office and Products Offered
Table 14. CART-CellTherapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global CART-CellTherapy Market Size by Region (2020-2025) & ($ millions)
Table 18. Global CART-CellTherapy Market Size Market Share by Region (2020-2025)
Table 19. Global CART-CellTherapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global CART-CellTherapy Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas CART-CellTherapy Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas CART-CellTherapy Market Size Market Share by Country (2020-2025)
Table 23. Americas CART-CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 24. Americas CART-CellTherapy Market Size Market Share byType (2020-2025)
Table 25. Americas CART-CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas CART-CellTherapy Market Size Market Share by Application (2020-2025)
Table 27. APAC CART-CellTherapy Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC CART-CellTherapy Market Size Market Share by Region (2020-2025)
Table 29. APAC CART-CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 30. APAC CART-CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe CART-CellTherapy Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe CART-CellTherapy Market Size Market Share by Country (2020-2025)
Table 33. Europe CART-CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 34. Europe CART-CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa CART-CellTherapy Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa CART-CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa CART-CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of CART-CellTherapy
Table 39. Key Market Challenges & Risks of CART-CellTherapy
Table 40. Key IndustryTrends of CART-CellTherapy
Table 41. Global CART-CellTherapy Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global CART-CellTherapy Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global CART-CellTherapy Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global CART-CellTherapy Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Novartis Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 46. Novartis CART-CellTherapy Product Offered
Table 47. Novartis CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Novartis Main Business
Table 49. Novartis Latest Developments
Table 50. Gilead Sciences Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 51. Gilead Sciences CART-CellTherapy Product Offered
Table 52. Gilead Sciences CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Gilead Sciences Main Business
Table 54. Gilead Sciences Latest Developments
Table 55. Bristol-Myers Squibb Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 56. Bristol-Myers Squibb CART-CellTherapy Product Offered
Table 57. Bristol-Myers Squibb CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Bristol-Myers Squibb Main Business
Table 59. Bristol-Myers Squibb Latest Developments
Table 60. J & J Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 61. J & J CART-CellTherapy Product Offered
Table 62. J & J CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. J & J Main Business
Table 64. J & J Latest Developments
Table 65. JWTherapeutics Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 66. JWTherapeutics CART-CellTherapy Product Offered
Table 67. JWTherapeutics CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. JWTherapeutics Main Business
Table 69. JWTherapeutics Latest Developments
Table 70.FOSUNKite Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 71.FOSUNKite CART-CellTherapy Product Offered
Table 72.FOSUNKite CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73.FOSUNKite Main Business
Table 74.FOSUNKite Latest Developments
Table 75. CARsgenTherapeutics (Pipeline) Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 76. CARsgenTherapeutics (Pipeline) CART-CellTherapy Product Offered
Table 77. CARsgenTherapeutics (Pipeline) CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. CARsgenTherapeutics (Pipeline) Main Business
Table 79. CARsgenTherapeutics (Pipeline) Latest Developments
Table 80. AutolusTherapeutics(Pipeline) Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 81. AutolusTherapeutics(Pipeline) CART-CellTherapy Product Offered
Table 82. AutolusTherapeutics(Pipeline) CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. AutolusTherapeutics(Pipeline) Main Business
Table 84. AutolusTherapeutics(Pipeline) Latest Developments
Table 85. SorrentoTherapeutics(Pipeline) Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 86. SorrentoTherapeutics(Pipeline) CART-CellTherapy Product Offered
Table 87. SorrentoTherapeutics(Pipeline) CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. SorrentoTherapeutics(Pipeline) Main Business
Table 89. SorrentoTherapeutics(Pipeline) Latest Developments
Table 90. Mustang Bio(Pipeline) Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 91. Mustang Bio(Pipeline) CART-CellTherapy Product Offered
Table 92. Mustang Bio(Pipeline) CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Mustang Bio(Pipeline) Main Business
Table 94. Mustang Bio(Pipeline) Latest Developments
Table 95. Bluebird Bio(Pipeline) Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 96. Bluebird Bio(Pipeline) CART-CellTherapy Product Offered
Table 97. Bluebird Bio(Pipeline) CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Bluebird Bio(Pipeline) Main Business
Table 99. Bluebird Bio(Pipeline) Latest Developments
Table 100. Cellectis(Pipeline) Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 101. Cellectis(Pipeline) CART-CellTherapy Product Offered
Table 102. Cellectis(Pipeline) CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Cellectis(Pipeline) Main Business
Table 104. Cellectis(Pipeline) Latest Developments
Table 105. AllogeneTherapeutics(Pipeline) Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 106. AllogeneTherapeutics(Pipeline) CART-CellTherapy Product Offered
Table 107. AllogeneTherapeutics(Pipeline) CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. AllogeneTherapeutics(Pipeline) Main Business
Table 109. AllogeneTherapeutics(Pipeline) Latest Developments
Table 110. Celyad(Pipeline) Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 111. Celyad(Pipeline) CART-CellTherapy Product Offered
Table 112. Celyad(Pipeline) CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Celyad(Pipeline) Main Business
Table 114. Celyad(Pipeline) Latest Developments
Table 1. CART-CellTherapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. CART-CellTherapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of CD19 -Targeted
Table 4. Major Players of BCMA -Targeted
Table 5. CART-CellTherapy Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global CART-CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 7. Global CART-CellTherapy Market Size Market Share byType (2020-2025)
Table 8. CART-CellTherapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global CART-CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 10. Global CART-CellTherapy Market Size Market Share by Application (2020-2025)
Table 11. Global CART-CellTherapy Revenue by Player (2020-2025) & ($ millions)
Table 12. Global CART-CellTherapy Revenue Market Share by Player (2020-2025)
Table 13. CART-CellTherapy Key Players Head office and Products Offered
Table 14. CART-CellTherapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global CART-CellTherapy Market Size by Region (2020-2025) & ($ millions)
Table 18. Global CART-CellTherapy Market Size Market Share by Region (2020-2025)
Table 19. Global CART-CellTherapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global CART-CellTherapy Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas CART-CellTherapy Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas CART-CellTherapy Market Size Market Share by Country (2020-2025)
Table 23. Americas CART-CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 24. Americas CART-CellTherapy Market Size Market Share byType (2020-2025)
Table 25. Americas CART-CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas CART-CellTherapy Market Size Market Share by Application (2020-2025)
Table 27. APAC CART-CellTherapy Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC CART-CellTherapy Market Size Market Share by Region (2020-2025)
Table 29. APAC CART-CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 30. APAC CART-CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe CART-CellTherapy Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe CART-CellTherapy Market Size Market Share by Country (2020-2025)
Table 33. Europe CART-CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 34. Europe CART-CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa CART-CellTherapy Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa CART-CellTherapy Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa CART-CellTherapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of CART-CellTherapy
Table 39. Key Market Challenges & Risks of CART-CellTherapy
Table 40. Key IndustryTrends of CART-CellTherapy
Table 41. Global CART-CellTherapy Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global CART-CellTherapy Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global CART-CellTherapy Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global CART-CellTherapy Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Novartis Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 46. Novartis CART-CellTherapy Product Offered
Table 47. Novartis CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Novartis Main Business
Table 49. Novartis Latest Developments
Table 50. Gilead Sciences Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 51. Gilead Sciences CART-CellTherapy Product Offered
Table 52. Gilead Sciences CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Gilead Sciences Main Business
Table 54. Gilead Sciences Latest Developments
Table 55. Bristol-Myers Squibb Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 56. Bristol-Myers Squibb CART-CellTherapy Product Offered
Table 57. Bristol-Myers Squibb CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Bristol-Myers Squibb Main Business
Table 59. Bristol-Myers Squibb Latest Developments
Table 60. J & J Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 61. J & J CART-CellTherapy Product Offered
Table 62. J & J CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. J & J Main Business
Table 64. J & J Latest Developments
Table 65. JWTherapeutics Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 66. JWTherapeutics CART-CellTherapy Product Offered
Table 67. JWTherapeutics CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. JWTherapeutics Main Business
Table 69. JWTherapeutics Latest Developments
Table 70.FOSUNKite Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 71.FOSUNKite CART-CellTherapy Product Offered
Table 72.FOSUNKite CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73.FOSUNKite Main Business
Table 74.FOSUNKite Latest Developments
Table 75. CARsgenTherapeutics (Pipeline) Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 76. CARsgenTherapeutics (Pipeline) CART-CellTherapy Product Offered
Table 77. CARsgenTherapeutics (Pipeline) CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. CARsgenTherapeutics (Pipeline) Main Business
Table 79. CARsgenTherapeutics (Pipeline) Latest Developments
Table 80. AutolusTherapeutics(Pipeline) Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 81. AutolusTherapeutics(Pipeline) CART-CellTherapy Product Offered
Table 82. AutolusTherapeutics(Pipeline) CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. AutolusTherapeutics(Pipeline) Main Business
Table 84. AutolusTherapeutics(Pipeline) Latest Developments
Table 85. SorrentoTherapeutics(Pipeline) Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 86. SorrentoTherapeutics(Pipeline) CART-CellTherapy Product Offered
Table 87. SorrentoTherapeutics(Pipeline) CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. SorrentoTherapeutics(Pipeline) Main Business
Table 89. SorrentoTherapeutics(Pipeline) Latest Developments
Table 90. Mustang Bio(Pipeline) Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 91. Mustang Bio(Pipeline) CART-CellTherapy Product Offered
Table 92. Mustang Bio(Pipeline) CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Mustang Bio(Pipeline) Main Business
Table 94. Mustang Bio(Pipeline) Latest Developments
Table 95. Bluebird Bio(Pipeline) Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 96. Bluebird Bio(Pipeline) CART-CellTherapy Product Offered
Table 97. Bluebird Bio(Pipeline) CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Bluebird Bio(Pipeline) Main Business
Table 99. Bluebird Bio(Pipeline) Latest Developments
Table 100. Cellectis(Pipeline) Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 101. Cellectis(Pipeline) CART-CellTherapy Product Offered
Table 102. Cellectis(Pipeline) CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Cellectis(Pipeline) Main Business
Table 104. Cellectis(Pipeline) Latest Developments
Table 105. AllogeneTherapeutics(Pipeline) Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 106. AllogeneTherapeutics(Pipeline) CART-CellTherapy Product Offered
Table 107. AllogeneTherapeutics(Pipeline) CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. AllogeneTherapeutics(Pipeline) Main Business
Table 109. AllogeneTherapeutics(Pipeline) Latest Developments
Table 110. Celyad(Pipeline) Details, CompanyType, CART-CellTherapy Area Served and Its Competitors
Table 111. Celyad(Pipeline) CART-CellTherapy Product Offered
Table 112. Celyad(Pipeline) CART-CellTherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Celyad(Pipeline) Main Business
Table 114. Celyad(Pipeline) Latest Developments
LIST OF FIGURES
Figure 1. CART-CellTherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CART-CellTherapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. CART-CellTherapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. CART-CellTherapy Sales Market Share by Country/Region (2024)
Figure 8. CART-CellTherapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global CART-CellTherapy Market Size Market Share byType in 2024
Figure 10. CART-CellTherapy in Lymphoma
Figure 11. Global CART-CellTherapy Market: Lymphoma (2020-2025) & ($ millions)
Figure 12. CART-CellTherapy in Multiple Myeloma
Figure 13. Global CART-CellTherapy Market: Multiple Myeloma (2020-2025) & ($ millions)
Figure 14. Global CART-CellTherapy Market Size Market Share by Application in 2024
Figure 15. Global CART-CellTherapy Revenue Market Share by Player in 2024
Figure 16. Global CART-CellTherapy Market Size Market Share by Region (2020-2025)
Figure 17. Americas CART-CellTherapy Market Size 2020-2025 ($ millions)
Figure 18. APAC CART-CellTherapy Market Size 2020-2025 ($ millions)
Figure 19. Europe CART-CellTherapy Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa CART-CellTherapy Market Size 2020-2025 ($ millions)
Figure 21. Americas CART-CellTherapy Value Market Share by Country in 2024
Figure 22. United States CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC CART-CellTherapy Market Size Market Share by Region in 2024
Figure 27. APAC CART-CellTherapy Market Size Market Share byType (2020-2025)
Figure 28. APAC CART-CellTherapy Market Size Market Share by Application (2020-2025)
Figure 29. China CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 33. India CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe CART-CellTherapy Market Size Market Share by Country in 2024
Figure 36. Europe CART-CellTherapy Market Size Market Share byType (2020-2025)
Figure 37. Europe CART-CellTherapy Market Size Market Share by Application (2020-2025)
Figure 38. Germany CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 39.France CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 40. UK CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa CART-CellTherapy Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa CART-CellTherapy Market Size Market Share byType (2020-2025)
Figure 45. Middle East & Africa CART-CellTherapy Market Size Market Share by Application (2020-2025)
Figure 46. Egypt CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 49.Turkey CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 52. APAC CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 53. Europe CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 55. United States CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 56. Canada CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 57. Mexico CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 58. Brazil CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 59. China CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 60. Japan CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 61. Korea CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 63. India CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 64. Australia CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 65. Germany CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 66.France CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 67. UK CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 68. Italy CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 69. Russia CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 70. Egypt CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 71. South Africa CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 72. Israel CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 73.Turkey CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 74. Global CART-CellTherapy Market Size Market ShareForecast byType (2026-2031)
Figure 75. Global CART-CellTherapy Market Size Market ShareForecast by Application (2026-2031)
Figure 76. GCC Countries CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 1. CART-CellTherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CART-CellTherapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. CART-CellTherapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. CART-CellTherapy Sales Market Share by Country/Region (2024)
Figure 8. CART-CellTherapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global CART-CellTherapy Market Size Market Share byType in 2024
Figure 10. CART-CellTherapy in Lymphoma
Figure 11. Global CART-CellTherapy Market: Lymphoma (2020-2025) & ($ millions)
Figure 12. CART-CellTherapy in Multiple Myeloma
Figure 13. Global CART-CellTherapy Market: Multiple Myeloma (2020-2025) & ($ millions)
Figure 14. Global CART-CellTherapy Market Size Market Share by Application in 2024
Figure 15. Global CART-CellTherapy Revenue Market Share by Player in 2024
Figure 16. Global CART-CellTherapy Market Size Market Share by Region (2020-2025)
Figure 17. Americas CART-CellTherapy Market Size 2020-2025 ($ millions)
Figure 18. APAC CART-CellTherapy Market Size 2020-2025 ($ millions)
Figure 19. Europe CART-CellTherapy Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa CART-CellTherapy Market Size 2020-2025 ($ millions)
Figure 21. Americas CART-CellTherapy Value Market Share by Country in 2024
Figure 22. United States CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC CART-CellTherapy Market Size Market Share by Region in 2024
Figure 27. APAC CART-CellTherapy Market Size Market Share byType (2020-2025)
Figure 28. APAC CART-CellTherapy Market Size Market Share by Application (2020-2025)
Figure 29. China CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 33. India CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe CART-CellTherapy Market Size Market Share by Country in 2024
Figure 36. Europe CART-CellTherapy Market Size Market Share byType (2020-2025)
Figure 37. Europe CART-CellTherapy Market Size Market Share by Application (2020-2025)
Figure 38. Germany CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 39.France CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 40. UK CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa CART-CellTherapy Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa CART-CellTherapy Market Size Market Share byType (2020-2025)
Figure 45. Middle East & Africa CART-CellTherapy Market Size Market Share by Application (2020-2025)
Figure 46. Egypt CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 49.Turkey CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries CART-CellTherapy Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 52. APAC CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 53. Europe CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 55. United States CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 56. Canada CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 57. Mexico CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 58. Brazil CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 59. China CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 60. Japan CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 61. Korea CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 63. India CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 64. Australia CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 65. Germany CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 66.France CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 67. UK CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 68. Italy CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 69. Russia CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 70. Egypt CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 71. South Africa CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 72. Israel CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 73.Turkey CART-CellTherapy Market Size 2026-2031 ($ millions)
Figure 74. Global CART-CellTherapy Market Size Market ShareForecast byType (2026-2031)
Figure 75. Global CART-CellTherapy Market Size Market ShareForecast by Application (2026-2031)
Figure 76. GCC Countries CART-CellTherapy Market Size 2026-2031 ($ millions)
More Publications
Current Research and Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy Market
US$ 4,650.00
March 2025
160 pages
Global CAR T Cell Therapy Market Opportunity & Clinical Pipeline Insight 2024
US$ 2,800.00
November 2018
400 pages
Global CAR T-Cell Therapy for Multiple Myeloma Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
US$ 3,480.00
December 2018
117 pages
Global CAR T-Cell Therapy for Multiple Myeloma Market Report 2020
US$ 2,350.00
June 2020
116 pages
